118 related articles for article (PubMed ID: 17255975)
21. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
[TBL] [Abstract][Full Text] [Related]
22. Head and neck squamous cell carcinoma in patients with Fanconi anemia.
Van Waes C
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):640-1. PubMed ID: 16027290
[No Abstract] [Full Text] [Related]
23. Tissue microarray - a high-throughput molecular analysis in head and neck cancer.
Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW
J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941
[TBL] [Abstract][Full Text] [Related]
24. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
25. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
26. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
[TBL] [Abstract][Full Text] [Related]
27. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
Braakhuis BJ; Leemans CR; Brakenhoff RH
Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
[TBL] [Abstract][Full Text] [Related]
28. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
Ferris RL; Grandis JR
Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
[No Abstract] [Full Text] [Related]
29. Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer?
Takes RP; Rinaldo A; Rodrigo JP; Devaney KO; Fagan JJ; Ferlito A
Head Neck; 2008 Apr; 30(4):525-38. PubMed ID: 18213721
[TBL] [Abstract][Full Text] [Related]
30. An alternative lifestyle for immortalized oral keratinocytes.
Reddel RR
J Clin Invest; 2001 Sep; 108(5):665-7. PubMed ID: 11544271
[No Abstract] [Full Text] [Related]
31. Expanding role of the medical oncologist in the management of head and neck cancer.
Choong N; Vokes E
CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
[TBL] [Abstract][Full Text] [Related]
32. TP53 mutations in head and neck cancer.
Perrone F; Bossi P; Licitra L
N Engl J Med; 2008 Mar; 358(11):1194-5; author reply 1195. PubMed ID: 18340660
[No Abstract] [Full Text] [Related]
33. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin.
Patmore HS; Ashman JN; Stafford ND; Berrieman HK; MacDonald A; Greenman J; Cawkwell L
Cancer Lett; 2007 Dec; 258(1):55-62. PubMed ID: 17920192
[TBL] [Abstract][Full Text] [Related]
35. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region.
Brant O; Hoffmann M; Kanappilly A; Görögh T; Gottschlich S
Anticancer Res; 2007; 27(5A):3301-5. PubMed ID: 17970074
[TBL] [Abstract][Full Text] [Related]
36. Gene symbol: TP53. Disease: squamous cell carcinoma of head and neck.
Roychoudhury S; Mitra S
Hum Genet; 2005 Feb; 116(3):233. PubMed ID: 15818805
[No Abstract] [Full Text] [Related]
37. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
[TBL] [Abstract][Full Text] [Related]
38. Head and neck cancer: reduce and integrate for optimal outcome.
Belbin TJ; Bergman A; Brandwein-Gensler M; Chen Q; Childs G; Garg M; Haigentz M; Hogue-Angeletti R; Moadel R; Negassa A; Owen R; Prystowsky MB; Schiff B; Schlecht NF; Shifteh K; Smith RV; Zheng X
Cytogenet Genome Res; 2007; 118(2-4):92-109. PubMed ID: 18000360
[No Abstract] [Full Text] [Related]
39. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection.
Lagiou P; Georgila C; Minaki P; Ahrens W; Pohlabeln H; Benhamou S; Bouchardy C; Slamova A; Schejbalova M; Merletti F; Richiardi L; Kjaerheim K; Agudo A; Castellsague X; Macfarlane TV; Macfarlane GJ; Talamini R; Barzan L; Canova C; Simonato L; Lowry R; Conway DI; McKinney PA; Znaor A; McCartan BE; Healy C; Nelis M; Metspalu A; Marron M; Hashibe M; Brennan PJ
Eur J Cancer Prev; 2009 Feb; 18(1):76-84. PubMed ID: 18830131
[TBL] [Abstract][Full Text] [Related]
40. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
